A recent study examined self-stigma in clinical depression. People with high self-stigma may delay seeking care, stop treatment, or report lower levels of satisfaction. Self-stigma may lead to reduced ...

A new update, led by researchers at the UNC School of Medicine and the Gillings School of Global Public Health, describes ...

That was the end of the conversation. Years later, in October 2022, I finally heard the words “major depressive disorder” from my psychiatrist. That was definitely a wake-up call.

Major depressive disorder is a disabling condition that adversely affects a person's family, work or school life, sleeping and eating habits, and general health.

Improvement in depression scores, response and remission were all found to be comparable with standard Deep TMS in non-inferiority trialBURLINGTON, Mass. and JERUSALEM, June 11, 2025 (GLOBE NEWSWIRE) ...

A phase 2 trial shows that a single dose of psilocybin provides lasting relief from symptoms of depression and anxiety. New ...

Many of us feel sluggish or less social when it’s colder. But seasonal affective disorder is more than just a slump.

A systematic review of almost 50 randomized clinical trials brings some clarity to concerns about antidepressant withdrawal ...

The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting ...

Of the 16 available MDD prediction instruments, researchers recommend using those assessing prior treatments and clinical characteristics.

The new funds will enable Draig Therapeutics to advance its lead candidate drug, DT-101, into phase two trials this year for major depressive disorder. The funding will also enable it to advance two ...

Even after symptoms subside, people who’ve experienced depression may retain a heightened sensitivity to punishment and negative feedback.